English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Cornell Health Services
Patient Daily
| Apr 10, 2026
Cornell Health Policy Center survey: 78% of experts say weakening vaccine liability protections would curb innovation
Trending
+
Pharmaceuticals
Patient Daily
| Apr 5, 2026
Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily
| Apr 7, 2026
ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+
Regulatory
Patient Daily
| Apr 9, 2026
Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+
Regulatory
Patient Daily
| Apr 8, 2026
Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
